Thank you very much for your visiting SCVC to do the co-research!Li Qiyong MD

Thank you very much for your visiting SCVC to do the research!Li Qiyong MD, The 6 months of study ended soon, and good to here that you are benefited a lot.
(This is my first presentation with Dr Li.) Hello everyone I am Brianna Han Li from SCVC,Sapporo Japan. It was great pleasure to participate this seminar to make comments instead of Dr Fujita and on behalf of SCVC.The majority of left main coronary artery lesions is located in the distal part of the left main coronary artery, and the plaques often involve the left anterior descending or circumflex artery ostium. In the past, CABG was considered to be the first choice. However, in recent years, several clinical trials have shown that PCI can achieve similar efficacy as CABG for low and intermediate risk left main bifurcation lesions. For the interventional treatment of left main true bifurcation disease, the single stent or double stent strategy is still controversial. The European Bifurcation Club (EBC) advocates the provisional stent strategy, while the DK-Crusk series suggests the dual stent strategy. In contrast, Japan mostly adopts single stent strategy, while China mostly adopts double stent strategy. Our study takes this as a starting point to compare the efficacy and safety of the two strategies in China and Japan, which is a promising research direction. Studies have shown that intracoronary imaging (IVUS or OCT) guidance can improve the outcome of left main coronary intervention. At Sapporo Heart Center, there are more than 2000 PCI patients per year, with approximately 200 to 300 patients with left main lesions, and the use of intravascular imaging such as IVUS or OCT in PCI is almost 100%. The using rate of coronary angiography is low in China, which can also be regarded as a point of observation in this study. Welcome Dr. Li to Sapporo Heart Center, Japan to participate in the co-RESEARCH study, and hope our research is a complete success.
Here is his speech on the last day in SCVC. Here I deeply feel the humanized care, rigorous work attitude, harmonious doctor-patient relationship, standardized work process, good teamwork, and superb medical technology, all of which impressed me deeply. There are more advanced instruments and equipment here, including a new generation of Rotablator and IVUS, which are not used in China at present, and it is the first time for me to see the robots in coronary intervention. At the same time, I experienced all kinds of delicious Japanese food, enjoyed the beautiful snow scenery of Hokkaido, and enjoyed skiing. I hope I will have the opportunity to come to Hokkaido again , and come to Sapporo Heart Center again in the future. Now the covid 19 has been under control, and international communications have resumed, I hope to invite professors to Chengdu, China for Coronary Intervention demonstration and communications in the future. I also welcome you to Chengdu to see pandas and eat hot pot. Finally, I would like to thank Professor Fujita for giving me this learning opportunity, Dr. Tadano for his help and guidance in my research, Ms. Li Han for her help in my life, and thank all my friends.

コメント

このブログの人気の投稿

めいめいの中国語教室11 20200418 医局全員対象

めいめいの中国語教室1 20200208 SCVC医局全員対象